BACKGROUND AND OBJECTIVES: Patients treated with percutaneous coronary intervention receive aspirin and P2Y12 ADP receptor inhibitors to reduce thrombotic complications. The choice of methodology for monitoring the effects of treatment and assessing its efficacy is still a topic of debate. We evaluated how decreased P2Y12 function influences platelet aggregate (thrombus) size measured ex vivo. METHODS AND RESULTS: We used confocal videomicroscopy to measure in real time the volume of platelet thrombi forming upon blood perfusion over fibrillar collagen type I at a wall shear rate of 1500 s(-1). The average volume was significantly smaller in 31 patients receiving aspirin and clopidogrel (19) or ticlopidine (12) than in 21 controls, but individual values were above the lower limit of the normal distribution, albeit mostly within the lower quartile, in 61.3% of cases. Disaggregation of platelet thrombi at later perfusion times occurred frequently in the patients. Vasodilator-stimulated phosphoprotein phosphorylation, reflecting P2Y12 inhibition, was also decreased in the patient group, and only 22.6% of individual values were above the lower normal limit. We found no correlation between volume of thrombus formed on collagen fibrils and level of P2Y12 inhibition, suggesting that additional and individually variable factors can influence the inhibitory effect of treatment on platelet function. CONCLUSIONS: Measurements of platelet thrombus formation in flowing blood reflects the consequences of antiplatelet therapy in a manner that is not proportional to P2Y12 inhibition. Combining the results of the two assays may improve the assessment of thrombotic risk.
BACKGROUND AND OBJECTIVES:Patients treated with percutaneous coronary intervention receive aspirin and P2Y12ADP receptor inhibitors to reduce thrombotic complications. The choice of methodology for monitoring the effects of treatment and assessing its efficacy is still a topic of debate. We evaluated how decreased P2Y12 function influences platelet aggregate (thrombus) size measured ex vivo. METHODS AND RESULTS: We used confocal videomicroscopy to measure in real time the volume of platelet thrombi forming upon blood perfusion over fibrillar collagen type I at a wall shear rate of 1500 s(-1). The average volume was significantly smaller in 31 patients receiving aspirin and clopidogrel (19) or ticlopidine (12) than in 21 controls, but individual values were above the lower limit of the normal distribution, albeit mostly within the lower quartile, in 61.3% of cases. Disaggregation of platelet thrombi at later perfusion times occurred frequently in the patients. Vasodilator-stimulated phosphoprotein phosphorylation, reflecting P2Y12 inhibition, was also decreased in the patient group, and only 22.6% of individual values were above the lower normal limit. We found no correlation between volume of thrombus formed on collagen fibrils and level of P2Y12 inhibition, suggesting that additional and individually variable factors can influence the inhibitory effect of treatment on platelet function. CONCLUSIONS: Measurements of platelet thrombus formation in flowing blood reflects the consequences of antiplatelet therapy in a manner that is not proportional to P2Y12 inhibition. Combining the results of the two assays may improve the assessment of thrombotic risk.
Authors: Marie Lordkipanidzé; Chantal Pharand; Thuy Anh Nguyen; Erick Schampaert; Donald A Palisaitis; Jean G Diodati Journal: Eur Heart J Date: 2008-09-30 Impact factor: 29.983
Authors: Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Richard D Hockett; John T Brandt; Joseph R Walker; Elliott M Antman; William Macias; Eugene Braunwald; Marc S Sabatine Journal: N Engl J Med Date: 2008-12-22 Impact factor: 91.245
Authors: Tabassome Simon; Céline Verstuyft; Murielle Mary-Krause; Lina Quteineh; Elodie Drouet; Nicolas Méneveau; P Gabriel Steg; Jean Ferrières; Nicolas Danchin; Laurent Becquemont Journal: N Engl J Med Date: 2008-12-22 Impact factor: 91.245
Authors: Gillian Stephens; Ming He; Connie Wong; Marzena Jurek; Hans-Christian Luedemann; Golnaz Shapurian; Kevin Munnelly; Craig Muir; Pamela B Conley; David R Phillips; Patrick Andre Journal: Thromb J Date: 2012-08-01
Authors: Susanne M de Witt; Frauke Swieringa; Rachel Cavill; Moniek M E Lamers; Roger van Kruchten; Tom Mastenbroek; Constance Baaten; Susan Coort; Nicholas Pugh; Ansgar Schulz; Inge Scharrer; Kerstin Jurk; Barbara Zieger; Kenneth J Clemetson; Richard W Farndale; Johan W M Heemskerk; Judith M E M Cosemans Journal: Nat Commun Date: 2014-07-16 Impact factor: 14.919
Authors: Nicholas Pugh; Ben D Maddox; Dominique Bihan; Kirk A Taylor; Martyn P Mahaut-Smith; Richard W Farndale Journal: Thromb Haemost Date: 2017-05-24 Impact factor: 5.249
Authors: Keith B Neeves; Abimbola A Onasoga; Ryan R Hansen; Jessica J Lilly; Diana Venckunaite; Meghan B Sumner; Andrew T Irish; Gary Brodsky; Marilyn J Manco-Johnson; Jorge A Di Paola Journal: PLoS One Date: 2013-01-23 Impact factor: 3.240